ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

LEGN Legend Biotech Corporation

42.45
-1.22 (-2.79%)
2024年6月15日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Legend Biotech Corporation LEGN NASDAQ Depository Receipt
  前日比 前日比 % 現在値 時刻
-1.22 -2.79% 42.45 09:00:00
始値 安値 高値 終値 前日終値
43.59 42.17 43.77 42.45 43.67
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/6/0405:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/6/0405:00BWLegend Biotech Shares Data on the Earliest Use to Date of..
2024/5/2921:00BWLegend Biotech to Participate in the Jefferies Global..
2024/5/2406:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/5/2406:00BWLegend Biotech to Highlight Leadership in CAR-T Cell Therapy..
2024/5/1320:10IHMARKETNEWSU.S. Futures Climb Amid High Expectations for Inflation..
2024/5/1320:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/5/1320:00BWLegend Biotech Reports First Quarter 2024 Results and Recent..
2024/4/2302:05BWCARVYKTI® (ciltacabtagene autoleucel) Approved by the..
2024/4/1121:00BWLegend Biotech to Host Investor Conference Call on First..
2024/4/0612:30BWLegend Biotech’s CARVYKTI® (ciltacabtagene autoleucel)..
2024/3/1921:30BWLegend Biotech Announces Publication of Inaugural..
2024/3/1604:15BWCARVYKTI® (ciltacabtagene autoleucel) Receives..
2024/3/1120:52EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/3/1120:00BWLegend Biotech Reports Fourth Quarter and Full Year 2023..
2024/3/1119:39IHMARKETNEWSU.S. Index Futures Dip Ahead of Inflation Data and Oracle’s..
2024/2/2908:46EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
2024/2/2809:47EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2403:10EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2321:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/2321:15BWLegend Biotech Announces Positive CHMP Opinion for CARVYKTI®..
2024/2/1510:34EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1322:00BWLegend Biotech to Host Investor Conference Call on Fourth..
2024/1/2323:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/2321:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/1006:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/0401:28BWLegend Biotech Announces Closing of License Transaction for..
2024/1/0322:30BWLegend Biotech Announces Closing of License Transaction for..
2024/1/0222:30BWLegend Biotech to Participate in the 42nd Annual J.P. Morgan..
2023/12/2800:00EDGAR2Form 144 - Report of proposed sale of securities
2023/12/2305:38EDGAR2Form 144 - Report of proposed sale of securities
2023/12/2305:21EDGAR2Form 144 - Report of proposed sale of securities
2023/12/2207:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/2206:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/1304:31EDGAR2Form 144 - Report of proposed sale of securities
2023/12/1209:30BWPatient-Reported Outcomes from the CARTITUDE-4 Study Showed..
2023/11/2020:25IHMARKETNEWSMonday’s Wall Street Highlights: GM, Microsoft, Citigroup,..
2023/11/2020:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/2020:00BWLegend Biotech Reports Third Quarter 2023 Results and Recent..
2023/11/1323:16DJNLegend Biotech Subsidiary in License Agreement With Novartis
2023/11/1322:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/1322:30BWLegend Biotech Announces Exclusive, Global License Agreement..
2023/11/0722:30BWLegend Biotech to Host Investor Conference Call on..
2023/11/0222:17BWLegend Biotech to Showcase Leadership in Multiple Myeloma..
2023/10/1806:39EDGAR2Form 144 - Report of proposed sale of securities
2023/10/1721:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/1706:20EDGAR2Form 144 - Report of proposed sale of securities
2023/9/2801:02EDGAR2Form 144 - Report of proposed sale of securities
2023/9/2521:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/2305:20EDGAR2Form 144 - Report of proposed sale of securities

最近閲覧した銘柄

Delayed Upgrade Clock